"Mueller and co-authors in presenting the theme that early stopping of a trial may give an overestimate of the drug's benefit use the example of a RCT using bisoprolol in patients undergoing noncardiac surgery which was stopped early because of an apparent large relative risk reduction in the treatment arm."